Shrivastava, A.; Marzolla, V.; Weidmann, H.; Caprio, M.; Tregouet, D.-A.; Zeller, T.; Karakas, M.
Design and Rationale of the ERA-CVD Consortium PREMED-CAD—Precision Medicine in Coronary Artery Disease. Biomolecules 2020, 10, 125.
https://doi.org/10.3390/biom10010125
AMA Style
Shrivastava A, Marzolla V, Weidmann H, Caprio M, Tregouet D-A, Zeller T, Karakas M.
Design and Rationale of the ERA-CVD Consortium PREMED-CAD—Precision Medicine in Coronary Artery Disease. Biomolecules. 2020; 10(1):125.
https://doi.org/10.3390/biom10010125
Chicago/Turabian Style
Shrivastava, Apurva, Vincenzo Marzolla, Henri Weidmann, Massimiliano Caprio, David-Alexandre Tregouet, Tanja Zeller, and Mahir Karakas.
2020. "Design and Rationale of the ERA-CVD Consortium PREMED-CAD—Precision Medicine in Coronary Artery Disease" Biomolecules 10, no. 1: 125.
https://doi.org/10.3390/biom10010125
APA Style
Shrivastava, A., Marzolla, V., Weidmann, H., Caprio, M., Tregouet, D.-A., Zeller, T., & Karakas, M.
(2020). Design and Rationale of the ERA-CVD Consortium PREMED-CAD—Precision Medicine in Coronary Artery Disease. Biomolecules, 10(1), 125.
https://doi.org/10.3390/biom10010125